NAD+ injections and IV infusions differ in route, dose, setting and what the price includes. A monthly home-injection offer cannot be compared directly with a single supervised IV visit. Neither the price nor the amount administered establishes better wellness outcomes.
REMEVi’s NAD+ program provides prescribed at-home care after clinical evaluation. REMEVi serves 49 states and Washington, DC, excluding Louisiana. The IV examples below describe other providers’ public offers, not a REMEVi IV service.
NAD+ is a coenzyme involved in cellular metabolism. Its biological role does not, by itself, prove that an injection improves energy, lifespan or recovery. Read what NAD+ is for background.
| Route | Where it goes | What to compare |
|---|---|---|
| Subcutaneous injection | Under the skin | Prescribed dose and frequency, vial concentration, usable supply and home-injection support |
| Intravenous infusion, also called an IV drip | Into a vein | Amount per session, infusion time, on-site monitoring and appointment fees |
| Oral supplement or precursor | Taken by mouth | Exact ingredient and product-specific evidence; supplement findings do not establish injectable outcomes |
Follow the prescription and pharmacy instructions for your exact preparation. An IV dose or infusion schedule is not a home-injection dosing guide. See NAD+ dosage questions and supplements versus injections.
Checked September 15, 2026; all amounts USD. These are selected provider-published offers, not a market average, recommendation or verified checkout quote. Confirm current terms directly.
| Provider and setting | Published route and amount | Advertised price | Limits of the comparison |
|---|---|---|---|
| RWACenter, Beverly Hills | Subcutaneous shot, 100 mg | $100 per shot | Clinic quote; confirm consultation charges |
| RWACenter, Beverly Hills | IV infusion, 100 mg | $160 per session | Supervised visit; confirm duration and extra fees |
| RWACenter, Beverly Hills | IV infusion, 500 mg | $460 per session | Different quantity from the 100 mg examples |
| Hone, telehealth | Subcutaneous injection; total milligrams not specified on the product page | $199/month on the product page | Membership and initial testing are also listed; confirm the complete quote |
Sources: RWACenter’s published prices and Hone’s NAD+ product page. RWACenter states that a provider consultation is required.
Hone’s public pages disagree: its editorial article lists $165/month for medication plus a $25 NAD-only membership, while its product page lists $199/month. Do not treat the older article’s number as a confirmed current total. Ask Hone which price and additional charges apply. Hone’s editorial cost article
A single session, a vial and a subscription are different units of purchase. Ask each provider for:
A lower price per milligram does not show equal absorption, clinical benefit or safety across routes. Do not choose a dose to make the price comparison work.
For REMEVi’s plan prices next to published IV-session and in-clinic ranges, see NAD+ injection cost.
A small pilot study followed eight participants receiving a six-hour IV infusion and three controls. It measured changes in NAD+ and related metabolites. It did not demonstrate durable wellness benefits or compare IV treatment with subcutaneous injections. Its findings cannot establish a home-injection dose or prove that either route improves longevity. Original intravenous pilot study
Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. That makes the exact preparation, pharmacy and clinical assessment important. It does not establish that two routes are equally effective or equally safe. FDA: compounded-drug risks
FDA has received reports of severe chills, shaking, vomiting and fatigue after NAD+ injectables, sometimes requiring medical care. It warns against food-grade ingredients in sterile compounding. These reports do not establish a frequency for an individual provider’s product. FDA: sterile-compounding ingredients
Ask the clinician what benefit is plausible, what remains uncertain and what symptoms should prompt medical care. Read our NAD+ side-effects guide. Do not use an unidentified injectable preparation.
The NAD+ page lists available formulations and current four-week subscription pricing. The published program includes clinical evaluation, prescribed preparation, applicable supplies, shipping and bilingual care coordination. Confirm the prescription’s route and supply with the care team.
Choose a program based on an individual clinical assessment and clear costs. An at-home format offers a different care setting; it is not proof of the same outcomes as IV therapy.
This article provides general education and does not replace advice for your individual health situation.
A home subscription, a clinic injection and an IV visit are different purchases. Compare route, milligrams supplied, number of doses, visit supervision, membership and shipping. Public price examples in this article are dated offers, not a national average.
The evidence cited here does not establish equivalent outcomes or a superior route for wellness. A small intravenous metabolite study cannot establish benefits or dosing for home subcutaneous injections.
The REMEVi program discussed here is prescribed at-home NAD+ care, not an IV infusion service. See the NAD+ product page for available formulations and current four-week pricing.
Confirm the prescribed route, concentration, total supply, pharmacy, sterile preparation, supplies, clinical follow-up and complete charge. Ask what is known and uncertain about the outcome you want.
Licensed US providers, transparent pricing, and medication shipped to your door. See the plans and start when you are ready.
See NAD+ injection plans